Clinical Trials on Diabetes Melltius, Type 2
Total 18584 results
-
AstraZenecaBristol-Myers SquibbCompletedStudy of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 DiabetesType 2 Diabetes MellitusKorea, Republic of, United States, Mexico, India, Puerto Rico, Russian Federation
-
Maastricht University Medical CenterNovo Nordisk A/SCompletedType 2 DiabetesNetherlands
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
CymaBay Therapeutics, Inc.TerminatedType 2 Diabetes MellitusUnited States, India
-
LG Life SciencesCompletedType 2 Diabetes MellitusKorea, Republic of
-
LG Life SciencesCompletedType 2 Diabetes MellitusKorea, Republic of
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States
-
Lexicon PharmaceuticalsCompletedType 2 Diabetes MellitusUnited States
-
Gilead SciencesCompletedType 2 Diabetes MellitusUnited States, Russian Federation, Israel, South Africa, India, Hungary, Ukraine, Canada, Czech Republic, Mexico, Poland
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
Tel Aviv UniversityCompletedType 2 Diabetes MellitusIsrael
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Chong Kun Dang PharmaceuticalCompletedType 2 Diabetes MellitusKorea, Republic of
-
Nagaoka Red Cross HospitalKurume UniversityUnknownType 2 Diabetes MellitusJapan
-
Tirang R. NeyestaniTehran University of Medical SciencesCompletedType 2 Diabetes MellitusIran, Islamic Republic of
-
Cytos Biotechnology AGCompletedType 2 Diabetes MellitusGermany, Switzerland
-
TakedaCompleted
-
TakedaCompletedType 2 Diabetes Mellitus
-
National Taiwan University HospitalNational Science Council, TaiwanCompleted
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusBrazil, Canada, Mexico, India, Australia, China, Korea, Republic of
-
GlaxoSmithKlineCompleted
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Poland, Germany, Netherlands, Argentina, Hungary, Chile
-
Landsteiner InstitutMedical University of Vienna; Lund University Hospital; Mein Hanusch-Krankenhaus and other collaboratorsCompletedType 2 Diabetes MellitusAustria
-
University of Campania "Luigi Vanvitelli"CompletedType 2 Diabetes MellitusItaly
-
National Institute of Nursing Research (NINR)CompletedType 2 Diabetes MellitusUnited States
-
Sanwa Kagaku Kenkyusho Co., Ltd.Completed
-
Diabetes Foundation, IndiaIndian Council of Medical ResearchCompletedT2DM (Type 2 Diabetes Mellitus) | NormoglycemiaIndia
-
Shanghai Zhongshan HospitalCompleted
-
Jeil Pharmaceutical Co., Ltd.Not yet recruitingType 2 Diabetes MellitusKorea, Republic of
-
Nanjing First Hospital, Nanjing Medical UniversityRecruitingType 2 Diabetes MellitusChina
-
Sun Yat-sen UniversityThe First Affiliated Hospital with Nanjing Medical University; Guangdong Provincial... and other collaboratorsCompletedType 2 Diabetes MellitusChina
-
BayerActive, not recruiting
-
Nanjing First Hospital, Nanjing Medical UniversityActive, not recruitingType 2 Diabetes MellitusChina
-
Rush University Medical CenterWithdrawn
-
TheracosCompletedType 2 Diabetes MellitusGermany, United States, Spain, Poland
-
AstraZenecaCompletedType 2 Diabetes MellitusKorea, Republic of
-
Oramed, Ltd.IntegriumCompletedDiabetes Type 2United States
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusGermany, United States
-
University of OxfordNIHR Collaboration for Leadership in Applied Health Research and Care (Oxford)CompletedType 2 Diabetes MellitusUnited Kingdom
-
Kun-Ho YoonTakedaCompletedType 2 Diabetes MellitusKorea, Republic of
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
KeyBioscience AGNordic Bioscience A/SCompletedType 2 Diabetes MellitusDenmark, Czechia, Poland, Moldova, Republic of, Romania, United Kingdom
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
University of PalermoAstraZeneca; University of CataniaUnknown
-
LG Life SciencesCompleted